Germany· DE-A57-1491182fdb034d10
Dabigatran Welding
A dabigatran etexilate product containing dabigatran etexilate, registered in Germany by Abdi Farma Gmbh. The same ATC class is registered in 16 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Dabigatran etexilate is registered in 16 of 19 countries.
Countries holding a registration under ATC B01AE07 (dabigatran etexilate), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 10 of them publish a price we can compare per daily dose
Dabigatran etexilate · ATC B01AE07
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dabigatran etexilate costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dabigatran etexilate · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.16
- IT Italy$2.17
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Dabigatran Etexilate
- Manufacturer
- Abdi Farma Gmbh
- Country
- Germany (DE)
- ATC code
- B01AE07
- ATC class
- Dabigatran etexilate
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
47 interactions on record for dabigatran etexilate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dabigatran etexilate · interactions on record
47 records
47 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Dabigatran etexilate in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDABIGATRAN ETEXILÁT +PHARMA+pharma arzneimittel gmbh, Graz
- PolandAbagatPolfarmex S.A.
- SwedenDabigatran Etexilate Accord 110 mg Kapsel, hårdAccord Healthcare S.L.U.
- United StatesDABIGATRANA-S Medication Solutions
- FinlandDabigatran Etexilate AccordOrifarm Oy
- United KingdomDabigatran etexilate 110mg capsulesMedical Valley Invest AB
- IcelandDabigatran etexilat AlembicAlembic Pharmaceutical Europe Limited, Malta
- BelgiumDabigatran Etexilaat HCS 110 mgHCS
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dabahib, Dabigatran Etexilaat Biocon
- Belgium · Dabigatran Etexilaat Hcs, Dabigatran Etexilaat Liconsa
- Bulgaria · Dabahib, Dabigatran Etexilate Laboratorios Liconsa
- Cyprus · Dabigatran Etexilate Gedeon Richter, Dabigatran Etexilate Viatris
- Czechia · Dabigatran Etexilát +pharma, Dabigatran Etexilate G.L. Pharma
- Denmark · Andabra, Dabigatran Etexilate "sandoz"
- Estonia · Dabigatran Etexilate Stada, Dabigatran Etexilate Viatris
- Spain · Andabra, Dabidose 150 Mg
- Finland · Dabigatran Etexilate Gedeon Richter, Dabigatran Etexilate Glenmark
- France · Dabigatran Etexilate Biogaran, Dabigatran Etexilate Eg
- United Kingdom (Northern Ireland) · Dabigatran Etexilate Glenmark Pharmaceuticals Europe, Dabigatran Etexilate Sandoz
- Greece · Andabra, Dabigatran Etexilate Ariti
- Croatia · Dabigatraneteksilat Abela, Dabigatraneteksilat Gedeon Richter
- Hungary · Dabigatran Etexilate Laboratorios Liconsa, Dabigatran Etexilate Sandoz
- Ireland · Dabigatran Etexilate Clonmel Healthcare, Dabigatran Etexilate Gedeon Richter
- Iceland · Dabigatran Etexilat Alembic, Dabigatran Etexilate Accord
- Italy · Andabra, Auralgan
- Liechtenstein · Dabigatran Etexilate Accord, Dabigatran Etexilate Teva
- Lithuania · Dabigatran Etexilate Sandoz, Dabigatran Etexilate Stada
- Luxembourg · Dabigatran Etexilate Eg, Dabigatran Etexilate Gedeon Richter
- Latvia · Dabigatran Etexilate Sandoz, Dabigatran Etexilate Stada
- Malta · Abagat, Auralgan
- Netherlands · Dabigatran Etexilaat Alembic, Dabigatran Etexilaat Biocon
- Norway · Dabigatran Accord, Dabigatran Etexilate Accord
- Poland · Abagat, Dabigartan Sanexcel
- Portugal · Dabigatran Azevedos, Dabigatran Etexilate Glenmark Arzneimittel Gmbh
- Romania · Dabigatran Etexilat Dr. Reddy’s, Dabigatran Etexilat Gemax Pharma
- Sweden · Dabigatran Etexilate G.L. Pharma, Dabigatran Etexilate Gedeon Richter
- Slovenia · Dabigatraneteksilat Gedeon Richter, Dabigatraneteksilat Hcs
- Slovakia · Dabahib, Dabigatran Etexilate Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5854d71-943d-439e-b2b2-98aff5d930e8 GET /v1/drugs/c5854d71-943d-439e-b2b2-98aff5d930e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Dabigatran Etexilate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about dabigatran etexilate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.